Semax

Approved in Russia/Ukraine

Also known as: MEHFPGP

Cognitive & NeuroprotectiveIntranasalSubcutaneous

A synthetic analog of ACTH(4-7) with neuroprotective and cognitive-enhancing properties. Used for stroke recovery and cognitive disorders.

Molecular Weight813.9 Da
Half-Life (t½)~3-5 minutes (effects last hours)
SequenceMet-Glu-His-Phe-Pro-Gly-Pro

Mechanism of Action

Upregulates BDNF and NGF expression, modulates serotonin and dopamine systems, enhances neuroplasticity, and has anti-inflammatory effects in the CNS.

Dosing Protocol

Intranasal: 200-600 mcg per nostril, 2-3x daily. Injectable: 500 mcg subcutaneous daily.

Open peptide calculator

Reconstitution

5mg vial + 2mL BAC water = 2500 mcg/mL.

Storage

Lyophilized: -20°C. Reconstituted: 2-8°C.

Side Effects

  • Mild headache
  • Nasal dryness

Key Research Findings

  • Improved cognitive function post-stroke in clinical trials
  • Increased BDNF expression by 1.4x in hippocampus
  • Neuroprotective against oxidative stress

Latest Verified Lab Report

No lab reports available for Semax yet.

Community-funded testing results will appear here.

Vendor Trust Leaderboard

For Semax

Trust leaderboard coming soon.

Vendor rankings based on verified lab test results.

Active Deals

Gen Peptide
10% OFF
G
Advertisement

Sponsored Ad Space

Advertise with us

Research Use Only

This information is provided for educational and research purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional before using any research compounds.